TITLE

How to Find a Trial

AUTHOR(S)
Smith, Ian K.
PUB. DATE
November 1999
SOURCE
Time International (South Pacific Edition);11/22/99, Issue 47, p76
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Offers information on patient enrollment in clinical drug trials. Researchers' need for patients as well as patients' need for treatment; Reasons adults do not participate in clinical drug trials; Where to locate trials. INSETS: Ace-ing It;Inside Information;Minitel Mini-Stroke;Couch Potatoes Arise...Slowly, by Janice M. Horowitz
ACCESSION #
2508025

 

Related Articles

  • Great Expectations: CROs Face Change in Italy. Corrado, Mario // Applied Clinical Trials;Nov2009, Vol. 18 Issue 11, p50 

    The article reports on the turbulent period of the clinical trials in Italy. It states that the country has a heterogeneous topology of the Contract Research Organizations (CRO) while the number of new trials per year has increased consistently from 500 in 2000 to 800 in 2007. On the other hand,...

  • Conducting Trials in Croatia. Aralica, Josip // Applied Clinical Trials;Nov2009, Vol. 18 Issue 11, p46 

    The article reports on the clinical research projects in Croatia while not being part of the European Union (EU). It mentions that European countries, even if not part of the EU, is not a hindrance to producing high-quality clinical research and meeting the target for the number of subjects....

  • They're Dying to Get In. Bjerklie, David // Time;4/22/2002, Vol. 159 Issue 16, p56 

    Discusses the difficulty of being able to participate in clinical trials in medicine. Benefits of the trials, including substantial doctor-patient interaction; Idea that it is not just the terminally ill who benefit from the attention, but also medically neglected or poorly informed subjects...

  • CHAPTER 26: Design Principles and Their Application in Preventive Field Trials. Brown, C. Hendricks // Handbook of Drug Abuse Prevention: Theory, Science, & Practice;2003, p523 

    The article provides a framework for assessing the quality of a preventive field trial. Such a framework is useful for three purposes. First, research scientists can direct their attention to a limited number of essential elements in designing and implementing new preventive trials. Second,...

  • Blinding in clinical trials and other studies. Day, Simon J; Altman, Douglas G // BMJ: British Medical Journal (International Edition);08/19/2000, Vol. 321 Issue 7259, p504 

    Discusses the relevance of allocation concealment, or blinding, in clinical trial practice. Importance of blinding in trials when response criteria is subjective; Difficulties involved in conducting double blind trials; Risk of bias associated with inadequate blinding; Use of blinding in other...

  • Clinical Trial watch.  // Urology Times;1/1/2006, Vol. 34 Issue 1, p25 

    The article presents a list of clinical trials related to urology that were conducted in the U.S. In one of the trials Paciltaxel, Carboplatin and Gemcltabine are used for the Treatment of patients with Advanced Transitional Cell Cancer of the Bladder. In another trial researchers are studying...

  • Retaining Subjects Is Harder Than Recruiting Them. Engfer, Doug // Applied Clinical Trials;Oct2004, Vol. 13 Issue 10, p70 

    The article discusses the difficulty of retention in contrast with recruitment of subjects in clinical trials in the U.S. Percentage of retention rates and dropout rates; Potential benefits of improving retention; Importance of communication and education between the researcher and the subject;...

  • My Life as a Guinea Pig. Reno, Jamie // Newsweek;8/6/2001, Vol. 138 Issue 6, p42 

    Focuses on the author, who participated in a clinical trial that helped preserve him from non-Hodgkin's lymphoma. His participation in a chemotherapy regimen called CHOP; His experiences in a clinical trial of a drug called Bexxar, which put him in remission; View that although clinical trials...

  • Personalized Medicine Development. Newman, Thomas J.; Freitag, Jeffrey J. // Applied Clinical Trials;Jul2011, Vol. 20 Issue 7, p30 

    The article discusses the role of the clinical research organization (CRO) that continues to develop as the popularity of personalized medicine grows in the U.S. It offers an overview of the services offered by CROs in assisting sponsors of personalized clinical trials. Also, it provides...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics